Literature DB >> 1700053

Immunogenicity and tolerogenicity of self-major histocompatibility complex peptides.

G Benichou1, P A Takizawa, P T Ho, C C Killion, C A Olson, M McMillan, E E Sercarz.   

Abstract

Mechanisms involved in self-antigen processing and presentation are crucial in understanding the induction of self-tolerance in the thymus. We examined the immunogenicity of determinants from major histocompatibility complex (MHC) molecules that are expressed in the thymus and have tested peptides derived from the polymorphic regions of class I and class II molecules. We found that two peptides corresponding to NH2 termini of the class II alpha and beta chains (Ak alpha 1-18 and Ak beta 1-16) could bind to self-Ak molecules with high affinity and, surprisingly, were immunogenic in that they could elicit strong proliferative T cell responses in B10.A mice (Ak, Ek). Neonatal injection of peptide Ak beta 1-16 resulted in complete unresponsiveness to this peptide at 8 wk of age showing that these T cells were susceptible to tolerance induction. We have also tested certain class I MHC peptides and showed that some can interact efficiently with class II MHC peptides to induce an autoreactive T cell proliferative response. Among these class I peptides is one (Dd 61-85) that has the capacity to bind to self-Ia without being immunogenic, and therefore represents an MHC determinant that had induced thymic self-tolerance. We conclude that some self-MHC molecules can be processed into peptides that can be presented in the context of intact class II molecules at the surface of antigen-presenting cells. Autoreactive T cells recognizing optimally processed self-peptide/MHC complexes are eliminated during development, whereas other potentially autoreactive T cells escape clonal inactivation or deletion. Incomplete tolerance to self-antigens enriches the T cell repertoire despite the fact that such T cells may eventually become involved in autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700053      PMCID: PMC2188673          DOI: 10.1084/jem.172.5.1341

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2.

Authors:  P Parham; C Clayberger; S L Zorn; D S Ludwig; G K Schoolnik; A M Krensky
Journal:  Nature       Date:  1987 Feb 12-18       Impact factor: 49.962

2.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes.

Authors:  C A Olson; L C Williams; E McLaughlin-Taylor; M McMillan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Interaction of monoclonal antibodies with MHC class I antigens on mouse spleen cells. II. Levels of expression of H-2K, H-2D, and H-2L in different mouse strains.

Authors:  S K Dower; D M Segal
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

5.  B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells.

Authors:  S Weiss; B Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

6.  How some T cells escape tolerance induction.

Authors:  G Gammon; E Sercarz
Journal:  Nature       Date:  1989-11-09       Impact factor: 49.962

7.  Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen.

Authors:  B Arnold; M Messerle; L Jatsch; G Küblbeck; U Koszinowski
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

8.  An intracellular self protein synthesized in macrophages is presented but fails to induce tolerance.

Authors:  B Stockinger; R H Lin
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

9.  Mechanisms influencing the immunodominance of T cell determinants.

Authors:  L Adorini; E Appella; G Doria; Z A Nagy
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

10.  T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP.

Authors:  H S de Koster; D C Anderson; A Termijtelen
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more
  23 in total

Review 1.  T cells causing immunological disease.

Authors:  R M Zinkernagel; H Pircher; P S Ohashi; H Hengartner
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Heat-shock proteins and the gamma delta T cell response in virus infections: implications for autoimmunity.

Authors:  P C Doherty; W Allan; M Eichelberger; S R Carding
Journal:  Springer Semin Immunopathol       Date:  1991

Review 3.  Self determinant selection and acquisition of the autoimmune T cell repertoire.

Authors:  G Benichou; R C Tam; P I Orr; M R Garovoy; E V Fedoseyeva
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

4.  Regulatory T cells in CNS injury: the simple, the complex and the confused.

Authors:  James T Walsh; Jonathan Kipnis
Journal:  Trends Mol Med       Date:  2011-07-07       Impact factor: 11.951

5.  Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.

Authors:  William Bracamonte-Baran; Jonathan Florentin; Ying Zhou; Ewa Jankowska-Gan; W John Haynes; Weixiong Zhong; Todd V Brennan; Partha Dutta; Frans H J Claas; Jon J van Rood; William J Burlingham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Viewing Autoimmune Pathogenesis from the Perspective of Antigen Processing and Determinant Hierarchy.

Authors:  Kamal D Moudgil
Journal:  Crit Rev Immunol       Date:  2020       Impact factor: 2.214

7.  Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens.

Authors:  K R Irvine; M R Parkhurst; E P Shulman; J P Tupesis; M Custer; C E Touloukian; P F Robbins; A G Yafal; P Greenhalgh; R P Sutmuller; R Offringa; S A Rosenberg; N P Restifo
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

8.  H2E-derived Ealpha52-68 peptide presented by H2Ab interferes with clonal deletion of autoreactive T cells in autoimmune thyroiditis.

Authors:  Nicholas K Brown; Daniel J McCormick; Chella S David; Yi-chi M Kong
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression.

Authors:  S Itescu; S Rose; E Dwyer; R Winchester
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

10.  A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis.

Authors:  D J Topham; B Nag; S Arimilli; S Sriram
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.